Can I have sex after taking ovulation-stimulating injections?

You can have sex after getting the ovulation-stimulating injection, but not too frequently. Try to wait about a week after the injection before having sex. This will make the effect more significant and the probability of success greater than before. There are also a few female friends who, if they feel adverse symptoms after the injection, they must find out the cause to avoid causing more serious diseases.

Pay attention to monitoring during medication

1. Measuring basal body temperature every day helps to understand ovarian ovulation;

2. Estrogen excretion measurement: After using this product for one week, collect urine or draw blood to measure estrogen every day. Use chorionic gonadotropin only 24 hours after the estrogen peak. If the estrogen value is too high, it is not advisable to give a large amount of HCG to avoid excessive stimulation of the ovaries.

3. Cervical mucus examination helps to understand the maturity of follicles or whether ovulation has occurred;

4. b-HCG immunoassay to detect early pregnancy; ⑥ For patients with high LH values, such as polycystic ovary syndrome, gonadotropin containing only FSH75 units should be used.

Adverse Reactions

1. When this product is used to stimulate ovulation, multiple follicles often develop at the same time, resulting in a high rate of multiple pregnancy, so immature newborns are also more common. Common adverse reactions include ovarian hyperstimulation syndrome (OHSS). In mild cases, there may be fullness or pain in the stomach and pelvis, abdominal pain, bloating, nausea, vomiting, diarrhea and other symptoms. The drug should be stopped immediately. Mild ovarian enlargement is common and disappears within 7 to 10 days. Moderate and severe OHSS may cause ascites and pleural effusion. If the ovaries enlarge to 10 cm in diameter, the patient should be hospitalized to avoid irreversible electrolyte imbalance or even death.

2. If the ovaries suddenly enlarge after stimulation, multiple follicles develop, accompanied by ovarian torsion or ovarian cyst rupture, there may even be blood accumulation in the abdominal cavity. Generally, symptoms may worsen 3 to 10 days after HCG injection to induce ovulation. The use of this product often increases the risk of arterial embolism. Some patients may have ascites, pleural effusion, arterial thromboembolism, and fever.

3. Ovarian enlargement and ovarian follicle rupture, leading to ovarian hyperstimulation syndrome such as peritoneal hemorrhage, pain, ascites, pleural reaction, oliguria, hypotension, and occasionally multiple births and gynecomastia in men.

Taboo

The following situations should be contraindicated: unexplained abnormal vaginal bleeding during ovulation induction, uterine fibroids, ovarian cysts or enlargement, adrenal insufficiency, and thyroid insufficiency. It should be used with caution in the following conditions: asthma, heart disease, epilepsy, migraine, renal impairment, pituitary hypertrophy or tumors. It is contraindicated for patients with ovarian insufficiency, polycystic ovary, intracranial lesions, and hypothyroidism and adrenal cortex function.

Patients who are allergic to this drug, have anatomical abnormalities of the reproductive tract, are pregnant, or have pituitary disease. Use with caution in patients with intracranial injury, adrenal cortical dysfunction, polycystic ovaries, or Stein-Leventhal syndrome. Before using the drug, make sure that the ovaries are not excessively enlarged or painful. If the blood estradiol content exceeds 1500pg/mL, or the total urinary estrogen exceeds 150μg/24hr, this drug is not recommended.